<em>GPX3</em> rs8177412 Polymorphism Modifies Risk of Upper Urothelial Tumors in Patients with Balkan Endemic Nephropathy

Current data suggest that aristolochic acid (AA) exposure is a putative cause of Balkan endemic nephropathy (BEN), a chronic kidney disease strongly associated with upper tract urothelial carcinoma. The cellular metabolism of AA is associated with the production of reactive oxygen species, resulting...

Full description

Bibliographic Details
Main Authors: Zana Radic Savic, Vesna Coric, Stojko Vidovic, Vanja Vidovic, Jelena Becarevic, Irina Milovac, Zorica Reljic, Bosa Mirjanic-Azaric, Ranko Skrbic, Radoslav Gajanin, Marija Matic, Tatjana Simic
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/59/8/1421
Description
Summary:Current data suggest that aristolochic acid (AA) exposure is a putative cause of Balkan endemic nephropathy (BEN), a chronic kidney disease strongly associated with upper tract urothelial carcinoma. The cellular metabolism of AA is associated with the production of reactive oxygen species, resulting in oxidative distress. <i>Purpose:</i> Therefore, the aim of this study was to analyze individual, combined and cumulative effect of antioxidant gene polymorphisms (<i>Nrf2</i> rs6721961, <i>KEAP1</i> rs1048290, <i>GSTP1AB</i> rs1695, <i>GSTP1CD</i> rs1138272, <i>GPX3</i> rs8177412 and <i>MDR1</i> rs1045642), as well as <i>GSTP1ABCD</i> haplotypes with the risk for BEN development and associated urothelial cell carcinoma in 209 BEN patients and 140 controls from endemic areas. <i>Experimental method:</i> Genotyping was performed using polymerase chain reaction (PCR) and PCR with confronting two-pair primers (PCR-CTTP) methods. <i>Results:</i> We found that female patients carrying both variant <i>GPX3</i> rs8177412 and <i>MDR1</i> rs1045642 genotypes in combination exhibited significant risk towards BEN (OR 1 = 3.34, 95% CI = 1.16–9.60, <i>p</i> = 0.025; OR 2 = 3.79, 95% CI = 1.27–11.24, <i>p</i> = 0.016). Moreover, significant association was determined between <i>GPX3</i>rs8174412 polymorphism and risk for urothelial carcinoma. Carriers of variant <i>GPX3</i>*TC + CC genotype were at eight-fold increased risk of BEN-associated urothelial tumors development. There was no individual or combined impact on BEN development and BEN-associated tumors among all examined polymorphisms. The haplotype consisting of variant alleles for both polymorphisms G and T was associated with 1.6-fold increased risk although statistically insignificant (OR = 1.64; 95% CI = 0.75–3.58; <i>p</i> = 0.21). <i>Conclusions:</i> Regarding <i>GPX3</i> rs8177412 polymorphism, the gene variant that confers lower expression is associated with significant increase in upper urothelial carcinoma risk. Therefore, BEN patients carrying variant <i>GPX3</i> genotype should be more frequently monitored for possible upper tract urothelial carcinoma development.
ISSN:1010-660X
1648-9144